Evaluation of Conflict of Interest in Economic Analyses of New Drugs Used in Oncology

Abstract

Although we did not identify bias in individual studies, these findings indicate that pharmaceutical company sponsorship of economic analyses is associated with reduced likelihood of reporting unfavorable results.